Clinical Trials in Maryland

Showing 12241-12260 of 23,284 trials

A Novel Approach to Infantile Spasms

NCT03347526

This study proposes to assess the efficacy of Cosyntropin Injectable Suspension, 1 mg/mL compared to vigabatrin. Additionally, this study proposes to determine efficacy of combination therapy of Cosyntropin Injectable Suspension, 1 mg/mL and vigabatrin to monotherapy Cosyntropin Injectable Suspension, 1mg/mL in children with new onset infantile spasms (IS).

Infantile Spasm

University of Colorado, Denver394 participantsStarted Apr 2018

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +11 more locations

COMPLETED19 miles

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

NCT04290676

Retrospective study to provide clinical outcomes with DEXYCU (dexamethasone intraocular suspension) 9%.

Cataract

EyePoint Pharmaceuticals, Inc.527 participantsStarted Nov 2019

Dothan, Alabama, United States • Hemet, California, United States • Laguna Hills, California, United States +19 more locations

A Novel Approach to Infantile Spasms

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

Find Trials by Condition in Maryland

A Clinical Evaluation of the Intersect ENT Sinus Device (ASCEND)

Comparison of Lokomat and Aquatic Exercise for Individuals With Chronic Incomplete Spinal Cord Injury

Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy

Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)

Treatment Protocol of Replagal for Patients With Fabry Disease

Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

BAX 855 Pediatric Study

Early Prophylaxis Immunologic Challenge (EPIC) Study

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

BAX 855 PK-guided Dosing